An Aggressive Case of Carcinoma of Cervix with Ovarian Metastasis

  • Debabrata Barmon
  • Haelom LiegiseEmail author
  • Amal Chandra Kataki
  • Dimpy Begum
  • Bipul Prasad Deka
  • Megha Nandwani
  • Parmita Tiwari
Case Report


With an estimated 570,000 cases and 311,000 deaths in 2018 worldwide, cervical cancer is ranked as the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women [1]. Cervical cancer ranks second in incidence and mortality behind breast cancer, and the performance of inadequate hysterectomy is not uncommon owing to the lack of proper investigative evaluations and/or a lack of expertise in primary care hospitals. The ideal treatment for salvage in this setting is radical parametrectomy with lymph node dissection or radical radiotheraphy. Since it may be technically difficult to perform an adequate radical surgery after a previous hysterectomy, definitive post-operative irradiation is usually advocated. Improved survival rates were reported after adjuvant radiotherapy in patients with no gross residual disease after hysterectomy; however, poor survival has been reported after adjuvant radiotherapy in patients with confirmed gross residual...


Compliance with ethical standards

Conflict of interest

The authors declare that there are no conflicts of interest.


  1. 1.
    Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRefGoogle Scholar
  2. 2.
    Hopkins MP, Peters WA, Andersen W, Morley GW. Invasive cervical treated initially by standard hysterectomy. Gynecol Oncol. 1990;36:7–12.CrossRefGoogle Scholar
  3. 3.
    International Agency for Research on Cancer (IARC). IARC handbooks of cancer prevention: volume 10-cervix cancer screening. Lyon: IARC Press; 2005. Accessed 21 June 2018.
  4. 4.
    Singleton HM, Orr JW. Primary surgical treatment of invasive cancer. In: Singleton HM, Orr JW, editors. Cancer of the cervix. Philadelphia: JB Lippincott Company; 1995. p. 174.Google Scholar
  5. 5.
    Landoni F, Zanagnolo V, Lovato-Diaz L, Maneo A, Rossi R, Gadducci A, et al. Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol Cancer. 2007;17:623–8.CrossRefGoogle Scholar
  6. 6.
    Ghandour FA, Attanoos R, Nahar K, et al. Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix. Histopathology. 1994;24:49–55.CrossRefGoogle Scholar
  7. 7.
    Elishaev E, Gilks CB, Miller D, et al. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms. Am J Surg Pathol. 2005;29:281–94.CrossRefGoogle Scholar
  8. 8.
    Carcangiu ML, Chambers JT, Voynick IM, et al. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol. 1990;94(247):254.Google Scholar
  9. 9.
    Wu HS, Yen MS, Lai CR, Ng HT. Ovarian metastasis from cervical carcinoma. Int J Gynaecol Obstet. 1997;57:173–8.CrossRefGoogle Scholar
  10. 10.
    Tabata N, Ichinoue K, Sakuragi N, et al. Incidence of ovarian metastasis in patients with cancer of the uterine cervix. Gynecol Oncol. 1986;28:255–61.CrossRefGoogle Scholar

Copyright information

© Association of Gynecologic Oncologists of India 2019

Authors and Affiliations

  1. 1.Department of Gynaecologic OncologyDr. B. Borooah Cancer InstituteGuwahatiIndia

Personalised recommendations